Hector R. Villarraga, M.D.

  • Cardio oncology: Evaluating with new imaging modalities for the possibility of early detection of cardiotoxicity related to chemotherapy or radiotherapy
  • Behavior of myocardial mechanical function in cardiomyopathies such as amyloid heart disease, hypertrophic cardiomyopathy, coronary artery disease, myocarditis, heart transplant, obesity and chemotherapy induced cardiomyopathy
  • Carpal tunnel tendon and synovial mechanics
  • Strain and stress echocardiography
  • Diastolic dysfunction in stress echocardiography
  • Right ventricular mechanical function
  1. 2004
    Resident - reduced to two years due to previous training.Carraway Methodist Medical Center
  2. 1997
    Fellow - Echocardiography, Level 3 Training (3/3)Division of Cardiovascular Diseases, Department of Internal Medicine
  3. 1995
    Fellow - Cardiovascular DiseasesUniversidad del Valle
  4. 1992
    Resident - Internal MedicineUniversidad del Valle
  5. 1985
    MDUniversidad del Valle


  1. United States Medical Licensing Examination (USMLE)
  2. National Board of Echocardiography
  3. American Board of Internal Medicine

Professional Highlights

  1. American Society of Echocardiography Research Committee Member, 2013-Present
  2. Award for Breast Cancer Perspective Study to Evaluate Early Cardiotoxicity, 2014-Present
  3. Award for Lymphoma Perspective Study to Evaluate Early Cardiotoxicity in Patients Undergoing Chemotherapy, 2013-present
  4. Co-Investigator in Patients Receiving VEGF-s For Renal and Advanced Colon Cancer For Detection of Early Cardiotoxicity With New Imaging Modalities 2013- present


Research Activities

See a description of research activities.